PPT-iFR vs FFR-guided coronary revascularization

iFRSwedeheart 5year outcome Matthias Götberg MD PhD Skane University Hospital Lund University Sweden on behalf of the iFRSwedeheart investigators Within the past 12 months I or my spousepartner have had a financial interestarrangement or affiliation with the organizations listed below. bypass grafting in treatment of unprotected left . main stenosis. Nordic–Baltic–British . left main . revascularisation study . (NOBLE. ). A . prospective, randomised, open-label. , non-inferiority trial. –. DEFINE-FLAIR . Justin E Davies, MD, . PhD on behalf of the DEFINE-FLAIR investigators. Hammersmith Hospital, . Imperial College London. F. unctional . L. esion . A. ssessment of . I. ntermediate stenosis to guide . VIABILITY. CORONARY ARTERY DISEASE. ACUTE CORONARY SYNDROME. Undergo . revascularisation. procedures. . Improved survival. Increased number of patients with residual LV dysfunction undergoing progressive LV remodeling and congestive heart failure. Revascularization in Stable Ischemic Heart Disease. Bobby Mathew, MD. LSU Internal Medicine, HO-II. Definitions. Recommendations for revascularization in the setting of symptomatic, stable ischemic heart disease; does not include revascularization in the setting of acute MI. Results from the FAME 2 trial. William . Fearon. , Bernard De . Bruyne. , . Nico. . Pijls. , David . Shilane. , Derek . Boothroyd. , . Pim. . Tonino. , . Emmanuele. . Barbato. , Peter . Juni. . 2021 ACC/AHA/SCAI Guideline of Coronary Artery Revascularization. Table 1. . Applying. . ACC/AHA Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in Patient Care . . Mark Nidorf, Aernoud Fiolet, Arend Mosterd, John Eikelboom, . Astrid Schut, Charley Budgeon, Jan Tijssen, Jan Hein Cornel, Peter Thompson. and the LoDoCo2 Investigators .  . Mark Nidorf has no declaration of interest . vs.. . c. oronary artery bypass for multi-vessel disease: a meta-analysis. . Nirav C Patel MD, Jonathan M Hemli MD, Karthik Seetharam MD, Annapoorna Uttara BS, Derek R Brinster MD,. . Luigi Pirelli MD, Chad . S. Elissa Altin, MD. Assistant Professor . Yale University. VA Connecticut. Disclosures. I have no disclosures.. Learning Objectives. Prevalence of angina in women. Prevalence of non-obstructive disease in women. 9 th CathLab Course, Nice 2015 FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst , Belgium 9 th Coronary Physiology in the CathLab Course, Nice 2015 • Institutional resea Intravascular Ultrasound . to Guide Percutaneous Coronary Intervention. . The FLAVOUR trial. Bon-Kwon Koo, MD, PhD. Seoul National University Hospital, Seoul, . Republic of Korea. Bon-Kwon Koo, MD, PhD. . infarction. . NSTEMI Guidelines. Benoit Lattuca. Nîmes . University. Hospital, France. ACTION . Study. Group. benoit.lattuca@gmail.com. Speaker's name : Benoît Lattuca, Nîmes. ☑ I have the . In collaboration with. www.CCClivecases.org. . from. . Cardiac Cath Lab, Mount Sinai Heart, NY, USA. . in. Association with . CME. . MEDI. Q. UEST. . Disclosures. on behalf of the OPTIMUM Investigators. O. utcomes of . P. ercutaneous . Revasculariza. TI. on. for . M. anagement of . S. U. rgically. Ineligible Patients with . M. ultivessel or Left Main Coronary Artery Disease: Primary Results from the .